New evidence for dual binding site inhibitors of acetylcholinesterase as improved drugs for treatment of Alzheimer's disease.
Zueva I, Dias J, Lushchekina S, Semenov V, Mukhamedyarov M, Pashirova T, Babaev V, Nachon F, Petrova N, Nurullin L, Zakharova L, Ilyin V, Masson P, Petrov K.
Zueva I, et al. Among authors: nachon f.
Neuropharmacology. 2019 Sep 1;155:131-141. doi: 10.1016/j.neuropharm.2019.05.025. Epub 2019 May 25.
Neuropharmacology. 2019.
PMID: 31132435